named programs · 3 · from sources
What they call their work
Financial Assistance Program
Application process and support for eligible patients needing help with medical costs based on income and need
Find a Doctor
Online directory and AI assistant tool to help patients locate and schedule appointments with over 6,000 providers across all medical specialties
NYU Langone Health MyChart
Secure patient portal for accessing medical records, reviewing and signing forms, and managing appointments and communications
activities · 10 groups
What they do
-
Biomedical Research and Innovation 2 activities
- Advance AI and genomics in disease predictionDeveloped an AI model to predict posthospital nursing care needs and hosted challenges to evaluate disease risk prediction models using genomics and AI for chronic conditions.
- Conduct translational and basic biomedical researchConducts research in autoimmune diseases (including lupus, rheumatoid arthritis, and psoriatic arthritis), diabetic complications, leukemia-related lung damage, and cancer metabolism. Research integrates immunology, genetics, microbiome science, and data-driven discovery, leading to therapeutic candidates and industry partnerships such as with argenx.
-
-
Advanced Surgical and Cardiac Care 1 activity
- Deliver advanced surgical and interventional proceduresOffers minimally invasive and innovative surgical options including ultrasound-guided carpal tunnel release and the LimFlow procedure for limb preservation in patients with critical limb ischemia.
-
-
Patient Portal and Digital Health Access 1 activity
- Enhance patient access and experience through digital toolsProvides a mobile app enabling patients to schedule appointments, communicate with care teams, access medical records, and use biometric hand scanning (PatientSecure) for accurate identification. Patients can also request and share medical records with authorized individuals.
-
-
Autoimmune Disease Research Funding 1 activity
- Establish and fund specialized research centersFunded the establishment of the Judith and Stewart Colton Center for Autoimmunity through a $10 million gift, followed by an additional $10 million in 2020 to expand its research capacity.
-
-
Comprehensive Primary and Specialty Care Networks 1 activity
- Operate a comprehensive academic medical system with integrated patient care, research, and educationNYU Langone Health operates an integrated academic medical system across more than 320 locations in the tristate area, encompassing 14.4 million square feet of facilities. The system delivers patient care through over 6,000 healthcare providers and supports medical education and research missions.
-
-
Skin Cancer Screening and Education 1 activity
- Provide skin cancer screening and personalized monitoringOffers skin cancer detection exams and develops individualized monitoring plans based on patient-specific risk factors.
-
-
Comprehensive Cancer Care and Survivorship 1 activity
- Provide specialized cancer care through NCI-designated Comprehensive Cancer CenterOperates the only NCI-designated Comprehensive Cancer Center on Staten Island and offers advanced oncology services, including co-development of Solavia, a next-generation oncology decision support suite with Dana-Farber Cancer Institute.
-
-
Medical Professional Education & Training 1 activity
- Support medical education and physician workforce developmentTrains medical students at NYU Grossman Long Island School of Medicine, with 40% of recent graduates remaining on Long Island to practice, contributing to regional healthcare capacity.
-
-
Volunteer-Driven Residential Care Support 1 activity
- Support volunteer engagement across campusesRecruits and trains volunteers to assist with greeting and directing visitors and supporting patient care units across NYU Langone campuses.
-
-
Uncategorized 3 activities
- Expand ambulatory and specialty care infrastructureHas opened multiple new ambulatory care centers, including a 54,000-square-foot facility in Patchogue, a 25,000-square-foot center in Riverhead, and a 260,000-square-foot facility in Garden City offering 32 clinical specialties. Also integrated over 60 physical therapy clinics into its network.
- Improve hospital performance and trauma care deliveryImproved quality metrics at NYU Langone Hospital—Suffolk, increasing CMS ratings from two to four stars within one year, reducing length of stay and emergency department wait times, and achieving verification to treat all adult trauma patients regardless of severity.
- Perform HIV-positive-to-HIV-positive organ transplantsNYU Langone Transplant Institute performs lung transplants from HIV-positive donors to HIV-positive recipients, including the world's first such procedure, under a research protocol approved by the HOPE Act. The institute has also performed dual lung and liver transplants on HIV-positive patients.
-
financials · form 990 · fy2023
revenue
Total revenue$9.45B
Contributions & grants$63.59M1%
Program service revenue$8.87B94%
Investment income$148.90M2%
Other revenue$374.50M
expenses
Total expenses$8.69B
Program expenses87%
Admin / overhead13%
Fundraising0%
Salaries & benefits$3.55B
Grants paid out$1.66B
Largest expense lineCompensation
balance sheet
Total assets$12.13B
Cash$2.37B
Investments$1.64B
Liabilities$5.52B
Net assets$6.61B
Liquid reserves5.5 mo
5 years on record · 2019–2023 · YoY revenue +6.6%
leadership · form 990 part vii · fy2023
Who runs it
paid leadership · 21
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| ROBERT I GROSSMAN MD | EX-OFFICIO, DEAN & CEO | 30 | $36.02M |
| DANIEL J WIDAWSKY | EVP/VICE DEAN, CFO (THROUGH 1/2024) | 30 | $11.62M |
| ANDREW W BROTMAN MD | EVP/VICE DEAN CHIEF CLINICAL OFFCR | 30 | $9.72M |
| VICKI MATCH SUNA AIA | EVP/VICE DEAN, REAL ESTATE | 30 | $6.12M |
| NADER MHERABI | EVP/VICE DEAN, CIO | 30 | $6.09M |
| NANCY SANCHEZ | EVP/VICE DEAN, HR AND ODL | 30 | $6.07M |
| FRITZ FRANCOIS MD | EVP/VICE DEAN CHIEF OF HOSP OPS | 60 | $5.67M |
| GRACE Y KO | EVP, DEVELOPMENT & ALUMNI AFFAIRS | 30 | $5.62M |
| DAFNA BAR-SAGI PHD | EVP/VICE DEAN CHIEF SCI OFFCR | 1 | $5.60M |
| ANNETTE JOHNSON JD | EVP/VICE DEAN, GENERAL COUNSEL | 30 | $5.57M |
| JOSEPH J LHOTA CFO FROM 224 | EVP/VICE DEAN, CFO & CHF OF STAFF | 30 | $5.21M |
| JOSEPH J GRECO MD | EVP. CHIEF OF HOSPITAL OPS NYULH LI | 60 | $4.54M |
| BRET RUDY MD | EVP. CHIEF OF HOSPITAL OPS NYULH BK | 60 | $4.50M |
| STEVEN B ABRAMSON MD | EVP/VICE DEAN EDUCATION | 19 | $4.44M |
| ROBERT J CERFOLIO MD MBA | FRMR EVP/VICE DEAN CHIEF OF HOS OPS | 0 | $3.49M |
| RALPH S MOSCA MD | CHAIR, CARDIOTHORACIC SURGERY | 11 | $3.46M |
| EDUARDO DEJESUS RODRIGUEZ MD | CHAIR, PLASTIC SURGERY | 25 | $3.37M |
| JOHN GOLFINOS MD | CHAIR, DEPT OF NEUROSURGERY | 17 | $3.29M |
| ANDREW HAMILTON PHD | FORMER EX-OFFICIO (THROUGH 6/2023) | 1 | $2.85M |
| LINDA G MILLS PHD | EX-OFFICIO | 1 | $1.44M |
| PIETRINA SCARAGLINO ESQ | ASSISTANT SECRETARY | 30 | $574K |
board members · 4
- ALICE M TISCH — TRUSTEE
- ALLEN R THORPE — TRUSTEE
- ANTHONY WELTERS ESQ — TRUSTEE
- BARRY F SCHWARTZ — TRUSTEE
relationships · 15
Who they work with
- Dana-Farber Cancer Institute Partner — Co-developed Solavia, a next-generation oncology decision support suite.
- Huntington Town Supervisor Ed Smyth Government — Engaged in planning process for the Melville academic medical center as part of the Melville Town Center development.
- Metro Physical & Aquatic Therapy Partner — Strategic alliance integrating over 60 clinics into NYU Langone's network to expand physical therapy access.
- NYU Grossman School of Medicine Partner — Collaborates on emergency medicine volunteer programs.
- Ronald O. Perelman Department of Dermatology Network — Department within NYU Langone that houses dermatology specialists focused on skin cancer detection and prevention.
- Suffolk County Executive Edward P. Romaine Government — Publicly supports NYU Langone’s expansion into Melville as a benefit to Long Island’s healthcare and economic development.
- Tel Aviv University Partner — Collaborating institution in the Colton Consortium for Autoimmunity.
- The Coltons Funder — Provided philanthropic investment critical to building NYU Langone's autoimmune disease research program.
- Town of Huntington Partner — Collaborating on alignment of the Melville academic medical center plans with the town's vision for the Melville Town Center.
- U.S. Food and Drug Administration Government — Sanctioned the research protocol enabling HIV-positive-to-HIV-positive lung transplants at NYU Langone Health.
- U.S. News & World Report Government — Organization that ranks NYU Langone Health No. 1 in multiple specialties in 2025.
- University of Pennsylvania Partner — Founding member of the Colton Consortium for Autoimmunity.
- Vizient Inc. Government — Independent organization that ranks NYU Langone Health as the top academic medical center in the U.S.
- Yale University Partner — Collaborating institution in the Colton Consortium for Autoimmunity.
- argenx Partner — Biopharmaceutical company engaged in a research relationship with NYU Langone resulting from Colton-funded work.
strategies · 3
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- AI-Enhanced Genomic Discoverymethodology: ai_genomics_challenge_modelBy combining genomics and artificial intelligence through collaborative scientific challenges, NYU Langone advances disease risk prediction because AI models can detect complex patterns in genetic data that improve early identification and intervention.
- Integrated Academic Medical Center Modelmethodology: integrated_academic_medical_centerBy integrating clinical care, medical education, and scientific research within a single academic culture, NYU Langone advances health outcomes and innovation because the synergy across missions accelerates discovery and improves patient care.
- Translational Research Integration in Autoimmunitymethodology: translational_research_integrationBy integrating clinical care with immunology, genetics, microbiome science, and data-driven discovery, NYU Langone accelerates translational research because this multidisciplinary convergence enables rapid development of personalized treatments for autoimmune diseases.